Skip to Content

Canopy Growth Corp CGC Stock Quote

| Rating as of

Morningstar‘s Stock Analysis CGC

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Canadian Market Continues to Weigh on Canopy's Performance, but U.S. Deals Still Offer Upside

Business Strategy and Outlook

| Kristoffer Inton |

Canopy Growth grows and sells cannabis products primarily in Canada, which accounts for roughly 50% of sales. Non-THC product sales account for about 30%.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics CGC

Company Profile CGC

Business Description

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.

1 Hershey Drive
Smiths Falls, ON, K7A 0A8, Canada
T +1 855 558-9333
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Jun 30, 2022
Fiscal Year End Mar 31, 2023
Employees 3,151

Related News CGC